Tag: Science Corp

2 articles

Market Moves

Science Corp Raises $230 Million to Commercialise PRIMA Retinal Implant

Science Corporation closes a $230 million Series C led by Khosla Ventures and Lightspeed, pushing its valuation past $1 billion as it targets European launch of the PRIMA vision-restoration implant by mid-2026.

Mar 6

Industry

Science Corp and Neurosoft Partner to Cut BCI Clinical Trial Costs

A new partnership between Science Corp and Neurosoft AI aims to dramatically reduce the cost and timeline of brain-computer interface clinical trials through shared infrastructure and software tools.

Mar 5

Stay Ahead of the Curve

Get the latest BCI news, breakthroughs, and market moves delivered to your inbox.

No spam. Unsubscribe anytime. We respect your privacy.